Summary

South Africa Animal Health Market Summary

The South Africa animal health market size was estimated at USD 958.47 million in 2024 and is projected to reach USD 1,808.59 million by 2033, growing at a CAGR of 7.4% from 2025 to 2033. The market is continuously growing driven by rising awareness of zoonotic and emerging diseases, increasing aquaculture and poultry production and government regulations and disease control programs.

Global health concerns, such as COVID-19, highlighted the importance of controlling zoonotic diseases. South Africa, with its diverse wildlife and livestock populations, faces unique risks of disease spillovers. Zoonotic diseases, account for over 60% of all recognized human illnesses and nearly 75% of emerging infectious diseases (EIDs). In developing countries such as South Africa, EIDs carry a mortality rate of 47.3%, posing a serious public health challenge. Majority of these emerging infections (71.8%) originate from wildlife, underscoring the critical need for strengthened surveillance, early detection, and One Health approaches that integrate animal, human, and environmental health strategies.

South Africa is witnessing growth in the aquaculture and poultry industries, driven by rising demand for affordable animal protein. According to U.S. Department of Agriculture (USDA) report of September 2024, South Africa’s chicken meat production is expected to rise 3% to 1.65 million tons in 2025, driven by industry recovery post-HPAI. Consumption is set to grow 2% to 1.88 million tons, supported by easing food inflation. Poultry and aquaculture face high disease risks, including bacterial, viral, and parasitic infections that can devastate production. Farmers invest in vaccines, feed supplements, water treatments, and biosecurity solutions to maintain yields and profitability. Poultry, being the largest protein source, demands continuous innovation in health management, while aquaculture expansion brings new opportunities for specialized veterinary pharmaceuticals. This diversification of animal farming strengthens the market for veterinary medicines, diagnostics, and nutritional products, positioning aquaculture and poultry health as important growth drivers.

Government-led programs targeting zoonotic diseases, foot-and-mouth disease (FMD), and avian influenza are major growth drivers. Regulatory authorities like the Department of Agriculture, Land Reform, and Rural Development (DALRRD) work with veterinary organizations to strengthen surveillance, vaccination campaigns, and biosecurity frameworks. Policies supporting antimicrobial stewardship and responsible veterinary drug usage are improving product adoption while promoting safer animal-derived food supply chains. Moreover, ongoing trade negotiations push farmers to meet international animal health standards, creating demand for certified vaccines and medicines. This regulatory environment strengthens trust in veterinary products, accelerates adoption, and fosters growth in the South African market.

South Africa Animal Health Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the South Africa Animal Health market report based on product, animal, disease, distribution channel, and end use.

• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Production Animals
o Poultry
o Swine
o Cattle
o Sheep & Goats
o Fish
• Companion Animals
o Dogs
o Cats
o Horses
o Pet Birds
o Others
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Biologics
o Vaccines
o Modified/ Attenuated Live
o Inactivated (Killed)
o Other Vaccines
o Other Biologics
• Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory
o Analgesics
o Others
• Medicated Feed Additives
• Diagnostics
o Consumables, reagents and kits
o Instruments and devices
• Equipment & Disposables
o Critical Care Consumables
o Anesthesia Equipment
o Fluid Management Equipment
o Temperature Management Equipment
o Rescue & Resuscitation Equipment
o Research Equipment
o Patient Monitoring Equipment
• Others
o Veterinary Telehealth
o Veterinary Software
o Livestock Monitoring
• Disease Outlook (Revenue, USD Million, 2021 - 2033)
• Poultry Diseases
o Avian Influenza
o Salmonellosis
o Coccidiosis
o Infectious Bronchitis
o Others
• Swine Diseases
o Porcine Reproductive and Respiratory Syndrome (PRRS)
o African Swine Fever
o Salmonellosis
o Porcine Circovirus (PCV)
o Others
• Cattle Diseases
o Bovine Respiratory Disease (BRD)
o Mastitis
o Foot and Mouth Disease (FMD)
o Bovine Viral Diarrhoea (BVD)
o Others
• Sheep & Goat Diseases
o Bacterial Diseases
o Parasitic Diseases
o Viral Diseases
o Others
• Fish/Aquaculture Diseases
o Bacterial Diseases
o Parasitic Diseases
o Others
• Canine Diseases
o Gastrointestinal
o Neurological
o Ophthalmic
o Others
• Feline Diseases
o Gastrointestinal
o Neurological
o Ophthalmic
o Others
• Equine Diseases
o Gastrointestinal
o Neurological
o Ophthalmic
o Others
• Pet Bird Diseases
o Gastrointestinal
o Ophthalmic
o Others
• Other Companion Animal Diseases
o Gastrointestinal
o Ophthalmic
o Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Retail
• E-Commerce
• Hospital/ Clinic Pharmacy
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Reference Laboratories
• Point-of-care Testing/In-house Testing
• Veterinary Hospitals & Clinics
• Others

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.3.6. Data analysis model
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Volume price analysis
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. South Africa Animal Health Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. South Africa Animal Health Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Legal landscape
3.3.2.3. Economic landscape
3.3.2.4. Social landscape
3.3.2.5. Technological landscape
3.3.2.6. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Estimated Animal Population, key species, 2024
3.3.5. Pricing Analysis
Chapter 4. South Africa Animal Health Market: Animal Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. South Africa Animal Health Market: Animal, market share 2024 & 2033
4.3. South Africa Animal Health Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
4.4. Production Animals
4.4.1. Production Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Poultry
4.4.2.1. Poultry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Swine
4.4.3.1. Swine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.4. Cattle
4.4.4.1. Cattle Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.5. Sheep & Goats
4.4.5.1. Sheep & Goats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.6. Fish
4.4.6.1. Fish Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Companion animals
4.5.1. Companion Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Dogs
4.5.2.1. Dogs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Cats
4.5.3.1. Cats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Horses
4.5.4.1. Horses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Pet birds
4.5.5.1. Pet birds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.6. Others
4.5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. South Africa Animal Health Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. South Africa Animal Health Market: Product, market share 2024 & 2033
5.3. South Africa Animal Health Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.4. Biologics
5.4.1. Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2. Vaccines
5.4.2.1. Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2.1.1. Modified/ Attenuated Live
5.4.2.1.1.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2.1.2. Inactivated (Killed)
5.4.2.1.2.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2.1.3. Other Vaccines
5.4.2.1.3.1. Other Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3. Other Biologics
5.4.3.1. Other Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Pharmaceuticals
5.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.2. Parasiticides
5.5.2.1. Parasiticides Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.3. Anti-infectives
5.5.3.1. Anti-infectives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.4. Anti-inflammatory
5.5.4.1. Anti-inflammatory Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.5. Analgesics
5.5.5.1. Analgesics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.6. Others
5.5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Medicated Feed Additives
5.6.1. Medicated Feed Additives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Diagnostics
5.7.1. Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7.2. Consumables, reagents and kits
5.7.2.1. Consumables, reagents and kits Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7.3. Instruments and devices
5.7.3.1. Instruments and devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Equipment & Disposables
5.8.1. Equipment & Disposables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8.2. Critical Care Consumables
5.8.2.1. Critical Care Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8.3. Anesthesia Equipment
5.8.3.1. Anesthesia Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8.4. Fluid Management Equipment
5.8.4.1. Fluid Management Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8.5. Temperature Management Equipment
5.8.5.1. Temperature Management Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8.6. Rescue & Resuscitation Equipment
5.8.6.1. Rescue & Resuscitation Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8.7. Research Equipment
5.8.7.1. Research Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8.8. Patient Monitoring Equipment
5.8.8.1. Patient Monitoring Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9.2. Veterinary Telehealth
5.9.2.1. Veterinary Telehealth Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9.3. Veterinary Software
5.9.3.1. Veterinary Software Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9.4. Livestock Monitoring
5.9.4.1. Livestock Monitoring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. South Africa Animal Health Market: By Disease Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. South Africa Animal Health Market: By Disease, market share 2024 & 2033
6.3. South Africa Animal Health Market Size & Trend Analysis, by Disease, 2021 to 2033 (USD Million)
6.4. Poultry Diseases
6.4.1. Poultry Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2. Avian Influenza
6.4.2.1. Avian Influenza Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Salmonellosis
6.4.3.1. Salmonellosis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Coccidiosis
6.4.4.1. Coccidiosis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.5. Infectious Bronchitis
6.4.5.1. Infectious Bronchitis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.6. Others
6.4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Swine Diseases
6.5.1. Swine Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. Porcine reproductive and respiratory syndrome (PRRS)
6.5.2.1. Porcine reproductive and respiratory syndrome (PRRS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. African Swine Fever
6.5.3.1. African Swine Fever Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. Salmonellosis
6.5.4.1. Salmonellosis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Porcine circovirus (PCV)
6.5.5.1. Porcine circovirus (PCV) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Others
6.5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Cattle Diseases
6.6.1. Cattle Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Bovine Respiratory Disease (BRD)
6.6.2.1. Bovine Respiratory Disease (BRD) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. Mastitis
6.6.3.1. Mastitis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. Foot and Mouth Disease (FMD)
6.6.4.1. Foot and Mouth Disease (FMD) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. Bovine Viral Diarrhoea (BVD)
6.6.5.1. Bovine Viral Diarrhoea (BVD) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. Others
6.6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Sheep & Goat Diseases
6.7.1. Sheep & Goat Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Bacterial Diseases
6.7.2.1. Bacterial Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Parasitic Diseases
6.7.3.1. Parasitic Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.4. Viral Diseases
6.7.4.1. Viral Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.5. Others
6.7.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Fish/Aquaculture Diseases
6.8.1. Fish/Aquaculture Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.2. Bacterial Diseases
6.8.2.1. Bacterial Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Parasitic Diseases
6.8.3.1. Parasitic Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. Others
6.8.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9. Canine Diseases
6.9.1. Canine Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9.2. Gastrointestinal
6.9.2.1. Gastrointestinal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9.3. Neurological
6.9.3.1. Neurological Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9.4. Ophthalmic
6.9.4.1. Ophthalmic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9.5. Others
6.9.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.10. Feline Diseases
6.10.1. Feline Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.10.2. Gastrointestinal
6.10.2.1. Gastrointestinal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.10.3. Neurological
6.10.3.1. Neurological Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.10.4. Ophthalmic
6.10.4.1. Ophthalmic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.10.5. Others
6.10.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.11. Equine Diseases
6.11.1. Equine Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.11.2. Gastrointestinal
6.11.2.1. Gastrointestinal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.11.3. Neurological
6.11.3.1. Neurological Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.11.4. Ophthalmic
6.11.4.1. Ophthalmic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.11.5. Others
6.11.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.12. Pet Bird Diseases
6.12.1. Pet Bird Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.12.2. Gastrointestinal
6.12.2.1. Gastrointestinal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.12.3. Ophthalmic
6.12.3.1. Ophthalmic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.12.4. Others
6.12.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.13. Other Companion Animal Diseases
6.13.1. Other Companion Animal Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.13.2. Gastrointestinal
6.13.2.1. Gastrointestinal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.13.3. Ophthalmic
6.13.3.1. Ophthalmic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.13.4. Others
6.13.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. South Africa Animal Health Market: Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. South Africa Animal Health Market: Distribution Channel, market share 2024 & 2033
7.3. South Africa Animal Health Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
7.4. Retail
7.4.1. Retail Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. E-Commerce
7.5.1. E-Commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Hospital/ Clinic Pharmacy
7.6.1. Hospital/ Clinic Pharmacy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. South Africa Animal Health Market: Distribution Channel Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. South Africa Animal Health Market: Distribution Channel, market share 2024 & 2033
8.3. South Africa Animal Health Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
8.4. Retail
8.4.1. Retail Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. E-Commerce
8.5.1. E-Commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Hospital/ Clinic Pharmacy
8.6.1. Hospital/ Clinic Pharmacy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. South Africa Animal Health Market: By End Use Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. South Africa Animal Health Market: By End Use, market share 2024 & 2033
9.3. South Africa Animal Health Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
9.3.1. Veterinary Reference Laboratories
9.3.1.1. Veterinary Reference Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.2. Point-of-care Testing/In-house Testing
9.3.2.1. Point-of-care Testing/In-house Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.3. Veterinary Hospitals & Clinics
9.3.3.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
9.3.4. Others
9.3.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Market Participant Categorization
10.2. Company Market Position Analysis/ Heat Map Analysis
10.3. Company Profiles
10.3.1. Boehringer Ingelheim International GmbH
10.3.1.1. Participant’s Overview
10.3.1.2. Financial Performance
10.3.1.3. Product Benchmarking
10.3.1.4. Strategic Initiatives
10.3.2. Zoetis Services LLC
10.3.2.1. Participant’s Overview
10.3.2.2. Financial Performance
10.3.2.3. Product Benchmarking
10.3.2.4. Strategic Initiatives
10.3.3. Virbac
10.3.3.1. Participant’s Overview
10.3.3.2. Financial Performance
10.3.3.3. Product Benchmarking
10.3.3.4. Strategic Initiatives
10.3.4. Merck & Co., Inc.
10.3.4.1. Participant’s Overview
10.3.4.2. Financial Performance
10.3.4.3. Product Benchmarking
10.3.4.4. Strategic Initiatives
10.3.5. Elanco
10.3.5.1. Participant’s Overview
10.3.5.2. Financial Performance
10.3.5.3. Product Benchmarking
10.3.5.4. Strategic Initiatives
10.3.6. Ceva Santé Animale
10.3.6.1. Participant’s Overview
10.3.6.2. Financial Performance
10.3.6.3. Product Benchmarking
10.3.6.4. Strategic Initiatives
10.3.7. Dechra
10.3.7.1. Participant’s Overview
10.3.7.2. Financial Performance
10.3.7.3. Product Benchmarking
10.3.7.4. Strategic Initiatives
10.3.8. Phibro Animal Health Corporation
10.3.8.1. Participant’s Overview
10.3.8.2. Financial Performance
10.3.8.3. Product Benchmarking
10.3.8.4. Strategic Initiatives
10.3.9. Bimeda Corporate (Afrivet)
10.3.9.1. Participant’s Overview
10.3.9.2. Financial Performance
10.3.9.3. Product Benchmarking
10.3.9.4. Strategic Initiatives
10.3.10. Bupo Animal Health (Pty) Ltd
10.3.10.1. Participant’s Overview
10.3.10.2. Financial Performance
10.3.10.3. Product Benchmarking
10.3.10.4. Strategic Initiatives
10.3.11. Vetoquinol
10.3.11.1. Participant’s Overview
10.3.11.2. Financial Performance
10.3.11.3. Product Benchmarking
10.3.11.4. Strategic Initiatives
10.3.12. IDEXX
10.3.12.1. Participant’s Overview
10.3.12.2. Financial Performance
10.3.12.3. Product Benchmarking
10.3.12.4. Strategic Initiatives
10.3.13. Avimune Inc.
10.3.13.1. Participant’s Overview
10.3.13.2. Financial Performance
10.3.13.3. Product Benchmarking
10.3.13.4. Strategic Initiatives
10.3.14. Afrigen Biologics and Vaccines
10.3.14.1. Participant’s Overview
10.3.14.2. Financial Performance
10.3.14.3. Product Benchmarking
10.3.14.4. Strategic Initiatives
10.3.15. Deltamune
10.3.15.1. Participant’s Overview
10.3.15.2. Financial Performance
10.3.15.3. Product Benchmarking
10.3.15.4. Strategic Initiatives
10.4. Strategy Mapping
10.1.1. Mergers & Acquisitions
10.1.2. Partnerships & Collaborations
10.1.3. Product launch
10.1.4. Others
10.5. List of other key players